Why Medicinal Marijuana Is the Anecdote to Neuropathy

Neuropathy is a peculiar, chronic spinal or tissue disorder stemming from a birth deformity, irregular nerve fibers, or exterior injuries causing tissue dysfunction. Essentially, the disease causes the scrambling or inaccurate readings of pain reception to the brain, causing victims a sensation of random, wide-spread, horrific pain (http://www.diabetes.org/living-with-diabetes/complications/neuropathy/)

Up until recently, Neuropathy has been regarded as virtually incurable, or the closest thing to it.

Current forms of medication to treat the different forms of neuropathy, such as duloxetine hydrochloride (Cymbalta), come with side-effects such as constipation, diarrhea, dry mouth, nausea, sometimes hot-flashes and dizziness, drowsiness, fatigue, low-blood pressure, nervousness, light-headedness, double-vision, and stinging, depending on the type of drug and what type of neuropathy it treats (http://www.healthcommunities.com/neuropathy/treatment.shtml).

No pharmaceutically developed substance has as significantly improved the symptoms of the neuropathic disorder as marijuana, with as many success cases within such a wide variety of the different forms of neuropathy.

A recent study done by the University of Glasgow, using two groups of patients suffering from allodynia neuropathic pain (a condition, usually found on the skin, in which one finds pain and discomfort from the pressure of clothing or sheets rubbing against the skin),  a total of 246 adults. The first group was sprayed with cannabis oil ,and the other, control group being told as much, however were only sprayed with a useless liquid (http://www.unitedpatientsgroup.com/blog/2014/03/13/study-cannabis-effectively-treats-neuropathic-pain/). The group exposed to THC reported significant improvements in pain and the ability to sleep, as well as an overall noticeable improvement in their condition, in contrast to sufferers whom were not. Subjects of the extensive study reported no negative side-effects and researchers assured none were likely to arise.

A cross-over study regarding HIV neuropathy, a neurological complication contracted by infection known to affect motor nerves, thoracic nerves, cranial nerves or autonomic nerves, was conducted by the US National Library of Medicine in 2011. The study was formulated in order to figure out the impact of the smoking of marijuana on HIV neuropathy sufferers. The technique of the study was over a series of phases, to test whether marijuana treatment would be effective over an extended period of time. No difference in the improvement of pain was found regarding the period of time in which cannabis was smoked, meaning that the effect of cannabis remained constant despite how long it is used. Subjects who managed to entirely complete the study in a controlled environment reported a much greater improvement than the placebo group. A handful of subjects of the trials reported smoking-related coughing, and periodic psychosis, known side-effect of smoking cannabis (http://www.ncbi.nlm.nih.gov/pubmed/24420962).

However, as noted in the previously mentioned study conducted toward allodynia neuropathy for THC/CBD along with an additional study regarding low-dose, vaporized cannabis conducted by the US National Library of Medicine a year after the initial study (http://www.ncbi.nlm.nih.gov/pubmed/23237736), new developments of cannabis are eradicating such risks.

From the data analyses and testimonials from researchers as well as sufferers and users of cannabis, it can be easily concluded that marijuana, preferably in vaporized or oil form, is the most effective form of treatment for virtually all forms of neuropathy.

Suggested Links:

http://journalofethics.ama-assn.org/2013/05/oped1-1305.html

http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm